You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

List of Excipients in API lisdexamfetamine dimesylate oral

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing lisdexamfetamine dimesylate oral

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Azurity Pharmaceuticals, Inc.	ARYNTA	lisdexamfetamine dimesylate oral	24338-019	HYDROCHLORIC ACID
Azurity Pharmaceuticals, Inc.	ARYNTA	lisdexamfetamine dimesylate oral	24338-019	METHYLPARABEN SODIUM
Azurity Pharmaceuticals, Inc.	ARYNTA	lisdexamfetamine dimesylate oral	24338-019	PROPYLENE GLYCOL
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for lisdexamfetamine dimesylate oral

Excipient focus: HYDROCHLORIC ACID

lisdexamfetamine dimesylate oral drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN SODIUM

lisdexamfetamine dimesylate oral drug variants containing METHYLPARABEN SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing METHYLPARABEN SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

lisdexamfetamine dimesylate oral drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN

lisdexamfetamine dimesylate oral drug variants containing PROPYLPARABEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing PROPYLPARABEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SACCHARIN

lisdexamfetamine dimesylate oral drug variants containing SACCHARIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing SACCHARIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

lisdexamfetamine dimesylate oral drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

lisdexamfetamine dimesylate oral drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

lisdexamfetamine dimesylate oral drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Azurity Pharmaceuticals, Inc.	lisdexamfetamine dimesylate oral	24338-019
>Company	>Ingredient	>NDC

lisdexamfetamine dimesylate oral drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.